X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (105) 105
female (87) 87
male (75) 75
index medicus (66) 66
adult (60) 60
middle aged (54) 54
oncology (46) 46
aged (43) 43
psychiatry (32) 32
chemotherapy (26) 26
neurosciences (25) 25
treatment outcome (24) 24
aged, 80 and over (20) 20
cancer (19) 19
prognosis (19) 19
antineoplastic combined chemotherapy protocols - therapeutic use (16) 16
disease-free survival (16) 16
expression (15) 15
serotonin (15) 15
adolescent (14) 14
metastasis (14) 14
analysis (13) 13
clinical neurology (13) 13
pharmacology & pharmacy (13) 13
care and treatment (12) 12
mutation (12) 12
medicine & public health (11) 11
retrospective studies (11) 11
survival (11) 11
colorectal cancer (10) 10
fluorouracil (10) 10
further section (10) 10
neoplasm staging (10) 10
platelets (10) 10
serotonin transporter (10) 10
therapy (10) 10
bipolar disorder (9) 9
blood platelets - metabolism (9) 9
trial (9) 9
animals (8) 8
antineoplastic agents - therapeutic use (8) 8
breast neoplasms - drug therapy (8) 8
colorectal neoplasms - pathology (8) 8
depression (8) 8
docetaxel (8) 8
fluorouracil - administration & dosage (8) 8
h-3 paroxetine binding (8) 8
immunotherapy (8) 8
leucovorin - administration & dosage (8) 8
mania (8) 8
obsessive-compulsive disorder (8) 8
oxaliplatin (8) 8
psychiatric status rating scales (8) 8
psychology (8) 8
serotonin plasma membrane transport proteins (8) 8
tumors (8) 8
bevacizumab (7) 7
biomedicine (7) 7
cell biology (7) 7
cisplatin (7) 7
efficacy (7) 7
imipramine (7) 7
phase-ii (7) 7
prospective studies (7) 7
young adult (7) 7
1st-line treatment (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
breast cancer (6) 6
breast neoplasms - pathology (6) 6
cancer research (6) 6
cancer therapies (6) 6
carcinoma (6) 6
cell line, tumor (6) 6
comorbidity (6) 6
genetics & heredity (6) 6
health aspects (6) 6
italy (6) 6
leucovorin (6) 6
liver (6) 6
liver neoplasms - secondary (6) 6
localization (6) 6
membrane transport proteins (6) 6
mice (6) 6
nerve tissue proteins (6) 6
quality of life (6) 6
research (6) 6
survival analysis (6) 6
survival rate (6) 6
[ (5) 5
age (5) 5
analysis of variance (5) 5
antineoplastic combined chemotherapy protocols - administration & dosage (5) 5
binding sites (5) 5
cancer patients (5) 5
cetuximab (5) 5
child (5) 5
cisplatin - administration & dosage (5) 5
colorectal neoplasms - drug therapy (5) 5
colorectal neoplasms - genetics (5) 5
combination (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CardioVascular and Interventional Radiology, ISSN 0174-1551, 12/2015, Volume 38, Issue 6, pp. 1523 - 1531
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2019, Volume 37, Issue 8_suppl, pp. 44 - 44
44 Background: The emerging role of immunotherapy (IT) in cancer treatments has increased the research about tumor microenvironment (TME), tumor infiltrating... 
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 06/2017, Volume 232, Issue 6, pp. 1571 - 1578
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. e15295 - e15295
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2019, Volume 37, Issue 4_suppl, pp. 669 - 669
669 Background: Nowadays the optimal treatment for mCRC beyond second line is still questioned. During last years, regorafenib and TAS-102 showed to improve... 
Journal Article
1999, ISBN 8886498721, xix, 501 p., [8] leaves of plates
Book
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. e15034 - e15034
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2019, Volume 37, Issue 4_suppl, pp. 671 - 671
671 Background: Hepatic resection is the gold standard treatment for pts with liver-limited mCRC with 5- and 10-yrs survival rates reaching up to 60% and 20%.... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 4_suppl, pp. 629 - 629
629 Background: Presently few options are available for pts with mCRC who failed standard treatments and prognosis remains grim. MGMT promoter methylation is a... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2015, Volume 33, Issue 3_suppl, pp. 724 - 724
724 Background: Treatment options for metastatic colorectal cancer (mCRC) patients refractory to chemotherapy are limited and clinical outcome is poor. In mCRC... 
Journal Article
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 7/2019, Volume 68, Issue 7, pp. 1179 - 1185
No standard treatment has been defined for metastatic uveal melanoma (mUM). Although clinical trials testing Nivolumab/Pembrolizumab for cutaneous melanoma did... 
Pembrolizumab | Liver metastases | Immunology | Medicine & Public Health | First line | Immunotherapy | Uveal melanoma | Oncology | Cancer Research | CELLS | ONCOLOGY | PD-L1 EXPRESSION | LIVER | EXPERIENCE | IMMUNOLOGY | IPILIMUMAB | Care and treatment | Analysis | Liver | Melanoma | Metastasis | Drug therapy | Cancer | PD-1 protein | Toxicity | PD-L1 protein | Clinical trials | Diagnosis | Survival | Patients | Disease control | Metastases | Original
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.